In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery
Hongfei Xu,1,* Hongyu Ji,1,2,* Zerong Li,1,3 Wenmei Qiao,1,4 Chenghao Wang,1 Jingling Tang1 1Department of Pharmaceutics, School of Pharmacy, Harbin Medical University, Harbin, 150086, People’s Republic of China; 2Department of Pharmacy, The Second Affiliated Hospital, Harbin Medical Unive...
Enregistré dans:
| Auteurs principaux: | Xu H, Ji H, Li Z, Qiao W, Wang C, Tang J |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/eef02cf796804bf697987333482c5b21 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Efecto de un inhibidor tirosina kinasa (imatinib) en pacientes con tumores estromales gastrointestinales metastásicos: Experiencia preliminar
par: Garrido S,Marcelo, et autres
Publié: (2007) -
Pulmonary artery dissection in long standing idiopathic pulmonary arterial hypertension: A case report
par: Luis Regalado, BS, MSc, et autres
Publié: (2022) -
Evidence base for specific pulmonary vasodilators in adults with congenital heart disease
par: Anton A. Shmalts, et autres
Publié: (2021) -
Hipofosfatemia inducida por drogas: fierro carboximaltosa e imatinib. Casos clínicos
par: Ivanovic-Zuvic,Danisa, et autres
Publié: (2020) -
Hipertensión pulmonar y embarazo
par: Valdés S,Gloria, et autres
Publié: (2002)